Shiraishi, Wataru
Yamasaki, Ryo
Hashimoto, Yu
Ko, Senri
Kobayakawa, Yuko
Isobe, Noriko
Matsushita, Takuya
Kira, Jun-ichi
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP16K09694)
Article History
Received: 23 January 2021
Accepted: 4 August 2021
First Online: 12 August 2021
Competing interests
: R.Y. has received honoraria from Teijin Pharma, Ono Pharmaceutical, Takeda Pharmaceutical, Eisai, Novartis, Nihon Pharmaceutical, and CSL Behring; J.K. is a consultant for Biogen Japan and Medical Review, and has received honoraria from Bayer Healthcare, Mitsubishi Tanabe Pharma, Nobelpharma, Otsuka Pharmaceutical, Sanofi KK, Chugai Pharmaceutical Co. Ltd., Teijin Pharma, Novartis Pharma, and Medical Review; the remaining authors declare no conflicts of interest.